| Restrictive rating and adverse selection in health insurance PH Born, ET Sirmans Journal of Risk and Insurance 87 (4), 919-933, 2020 | 16 | 2020 |
| The impact of market power and economies of scale on large group health insurer profitability PH Born, L Hughen, ET Sirmans Journal of Insurance Issues 43 (2), 43-63, 2020 | 6 | 2020 |
| Regret in health insurance post‐purchase behavior PH Born, ET Sirmans Risk Management and Insurance Review 22 (2), 207-219, 2019 | 6 | 2019 |
| Individual Market Underwriting Profitability in Health Insurance. PH Born, ET Sirmans Journal of Insurance Regulation 37 (7), 2018 | 6 | 2018 |
| Are health insurers in multiple lines of business less profitable? An examination of scope economies in health insurance PH Born, A Cook, ET Sirmans, C Yang Journal of Risk and Insurance 90 (1), 185-212, 2023 | 5 | 2023 |
| A Comparison of the Risk Management and Own Risk Solvency Assessment Model Act and Insurer Ratings. ET Sirmans, KA McCullough Journal of Insurance Regulation 36 (3), 2017 | 5 | 2017 |
| Health insurers' use of quality improvement expenses to achieve a minimum medical loss ratio requirement PH Born, ET Sirmans, P Steinorth Journal of Risk and Insurance 90 (1), 123-154, 2023 | 3 | 2023 |
| Managed care or carefully managed? Management of underwriting profitability by health insurers PH Born, EM Eastman, ET Sirmans The Geneva Papers on Risk and Insurance-Issues and Practice 48 (1), 5-31, 2023 | 3 | 2023 |
| (Relative) Status Quo Effects on Customer Loyalty in Satisfaction and Trust Relationships in Insurance SA Taylor, ET Sirmans Journal of Consumer Satisfaction, Dissatisfaction and Complaining Behavior …, 2019 | 2 | 2019 |
| Medical cannabis laws lower individual market health insurance premiums AC Cook, ET Sirmans, A Stype International Journal of Drug Policy 119, 104143, 2023 | 1 | 2023 |
| New post‐ACA insurance data highlights health insurer spending on health care quality E Tice Sirmans, P Steinorth Risk Management and Insurance Review 23 (2), 209-218, 2020 | 1 | 2020 |
| Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures? AC Cook, ET Sirmans, B Wells The Geneva Papers on Risk and Insurance-Issues and Practice 49 (1), 212-226, 2024 | | 2024 |
| The impact of monitor choice on insurer loss reserves J Bisco, K McCullough, HM Montesinos Yufa, ET Sirmans Risk Management and Insurance Review 26 (1), 83-105, 2023 | | 2023 |
| Financial Sector Growth and Annuitization: Evidence from the United States P Born, HM Montesinos-Yufa, ET Sirmans The International Review of Financial Consumers (IRFC) 6 (1), 35-44, 2021 | | 2021 |
| Spillover effects of increased health insurance enrollment on workers’ compensation insurance CB Baggett, CR Cole, G Crowley, ET Sirmans Risk Management and Insurance Review 23 (1), 53-74, 2020 | | 2020 |
| The Role of Asymmetric Information in the US Health Insurance Market ET Sirmans The Florida State University, 2017 | | 2017 |
| The Impact of Medical Cannabis Laws on Private Health Insurer Financial Metrics RA Smith, A Cook, JD Frederick, ET Sirmans Available at SSRN 4844685, 0 | | |
Patricia BornFlorida State University在 business.fsu.edu 的电子邮件经过验证
